Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.312 EUR | 0.00% | +6.85% | -23.90% |
Apr. 30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 11 | Biofrontera Files Prospectus for Potential Secondary Stock Offerings | MT |
Business Summary
Number of employees: 92
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals and Medical Products
100.0
%
| 26 | 100.0 % | 32 | 100.0 % | +25.30% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
68.9
%
| 17 | 66.6 % | 22 | 68.9 % | +29.70% |
Germany
19.4
%
| 5 | 18.5 % | 6 | 19.4 % | +31.37% |
Spain
5.4
%
| - | - | 2 | 5.4 % | - |
Other European Countries
3.7
%
| - | - | 1 | 3.7 % | - |
United Kingdom
2.2
%
| - | - | 1 | 2.2 % | - |
Other Regions
0.3
%
| 0 | 1.3 % | 0 | 0.3 % | -69.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 55 | 22-09-11 | |
Anke zur Muehlen
IRO | Public Communications Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 21-12-13 | |
Director/Board Member | - | 21-12-13 | |
Heikki Lanckriet
BRD | Director/Board Member | 47 | 21-12-13 |
Helge Lubenow
BRD | Director/Board Member | 56 | 21-12-13 |
Director/Board Member | 65 | 22-08-22 | |
Jörgen Thielmann
BRD | Director/Board Member | - | 21-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,038,431 | 984,451 ( 32.40 %) | 0 | 32.40 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BIOFRONTERA INC. 7.86% | 400,000 | 7.86% | 616,000 $ |
Company contact information
Sector
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- B8F Stock
- B8F Stock
- Company Biofrontera AG